Premium
Expression of IFN‐γ before and after treatment of oral lichen planus with 0.1% fluocinolone acetonide in orabase
Author(s) -
YoungnakPiboonratanakit Pornpan,
Dhanuthai Kittipong,
Thongprasom Kobkan,
Luckprom Pimporn,
Sarideechaigul Wilairat,
Luangjarmekorn Lakana,
Azuma Miyuki
Publication year - 2009
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.2009.00805.x
Subject(s) - oral lichen planus , peripheral blood mononuclear cell , pathogenesis , medicine , psoriasis , immunohistochemistry , biopsy , immune system , pathology , autoimmune disease , fluocinolone acetonide , immunology , dermatology , gastroenterology , biology , disease , in vitro , biochemistry
Background: Oral lichen planus (OLP) is a common chronic inflammatory mucosal disease in which T‐cell‐mediated immune responses are implicated in the pathogenesis. The purpose of this study was to investigate the effect of 0.1% fluocinolone acetonide in orabase (FAO) on the in situ expression of IFN‐γ in patients with OLP. Methods: Twenty OLP patients were enrolled in this study. Biopsy specimens and serum samples were obtained before and 1‐month after the treatment with 0.1% FAO. In situ expression and serum levels of IFN‐γ were determined using immunohistochemistry and ELISA, respectively. Results: The number of IFN‐γ‐positive mononuclear cells in OLP lesions before the treatment was significantly higher as compared with that after the treatment. Similarly, the mean number of total mononuclear cells was clearly decreased after the treatment. However, the serum levels of IFN‐γ were not detectable. Conclusions: Our results suggest that IFN‐γ expression in OLP tissue may involve in the immunopathogenesis and the treatment with 0.1% FAO had an immunomodulating effect on the decrease of IFN‐γ.